OverviewSuggest Edit
Alector is a clinical-stage biopharmaceutical company that develops therapies for the treatment of neurodegenerative diseases. It offers AL001, a regulator of immune activity in the brain with genetic links to multiple neurodegenerative disorders, including frontotemporal dementia (FTD), Alzheimer’s disease, and Parkinson’s disease.
| Type | Public | |
| Founded | 2013 | |
| HQ | South San Francisco, CA, US | Map |
| Website | alector.com |
Recent NewsAll News
Key People/Management at Alector
Arnon Rosenthal
Shehnaaz Suliman
Robert King
Sabah Oney
Robert Paul
Calvin yu
Alector Office Locations
Alector Financials and Metrics
Alector Revenue
| USD | |
|---|---|
Revenue (FY, 2020) | 21.1m |
Net income (FY, 2020) | (190.2m) |
EBIT (FY, 2020) | (195.2m) |
Market capitalization (4-Jun-2021) | 1.6b |
Closing stock price (4-Jun-2021) | 19.5 |
Cash (31-Dec-2020) | 50.0m |
EV | 1.6b |
| USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
|---|---|---|---|---|---|---|---|---|
Net Income | (8.4m) | (19.6m) | (34.9m) | (18.6m) | (43.1m) | (74.9m) | (40.0m) | (85.3m) |
Depreciation and Amortization | 212.0k | 464.0k | 743.0k | 298.0k | 1.1m | 2.4m | 1.4m | 2.9m |
Accounts Payable | (783.0k) | (830.0k) | (604.0k) | 683.0k | 414.0k | 132.0k | 3.1m | 4.4m |
Cash From Operating Activities | 184.5m | 167.5m | 145.1m | (23.6m) | (41.6m) | (70.5m) | (32.3m) | (78.3m) |
| USD | FY, 2017 |
|---|---|
Financial Leverage | -4.5 x |
Alector Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| Alector LLC |
Alector Revenue Breakdown
Alector revenue breakdown by business segment: 100.0% from Collaboration
Alector Cybersecurity Score
Alector Environment, Social & Governance (ESG) Ratings
Alector Online and Social Media Presence
Alector's Trends
Alector News and Updates
Alector to Present at Upcoming Virtual Healthcare Conferences
Alector Reports 2021 First Quarter Financial Results and Provides Business Update
Alector to Present at Stifel’s 3rd Annual CNS Day
Thinking about buying stock in PLBY Group, Livexlive Media, Alector, Pixelworks, or Frequency Therapeutics?
Alector Announces First Participant Dosed in Phase 2 Study Evaluating AL002 in Individuals with Early Alzheimer’s Disease
Alector Announces Departure of Chief Business Officer
Alector Frequently Asked Questions
When was Alector founded?
Alector was founded in 2013.
Who are Alector key executives?
Alector's key executives are Arnon Rosenthal, Shehnaaz Suliman and Robert King.
How many employees does Alector have?
Alector has 126 employees.
What is Alector revenue?
Latest Alector annual revenue is $21.1 m.
What is Alector revenue per employee?
Latest Alector revenue per employee is $167.4 k.
Who are Alector competitors?
Competitors of Alector include ACADIA Pharmaceuticals, Verge Genomics and Encoded Therapeutics.
Where is Alector headquarters?
Alector headquarters is located at 131 Oyster Point Blvd #600, South San Francisco.
Where are Alector offices?
Alector has offices in South San Francisco and Milpitas.
How many offices does Alector have?
Alector has 2 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies